Quantbot Technologies LP Takes $12.76 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Quantbot Technologies LP acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to its most recent disclosure with the SEC. The fund acquired 25,793 shares of the healthcare conglomerate’s stock, valued at approximately $12,760,000. UnitedHealth Group makes up about 0.7% of Quantbot Technologies LP’s holdings, making the stock its 4th largest position.

Other large investors have also recently made changes to their positions in the company. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. CGC Financial Services LLC raised its holdings in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $31,000. LFA Lugano Financial Advisors SA raised its holdings in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. Finally, Red Tortoise LLC raised its holdings in shares of UnitedHealth Group by 45.1% during the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock worth $36,000 after acquiring an additional 23 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.4 %

Shares of UNH stock traded up $7.17 during mid-day trading on Friday, hitting $511.53. The stock had a trading volume of 3,532,475 shares, compared to its average volume of 4,236,860. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm has a market capitalization of $470.81 billion, a P/E ratio of 30.93, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60. The firm’s 50-day moving average is $499.20 and its two-hundred day moving average is $500.05. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business earned $6.26 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is 51.34%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on UNH shares. TD Cowen decreased their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Tuesday. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Robert W. Baird assumed coverage on UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price on the stock. Finally, Wells Fargo & Company cut their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $581.44.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.